¿À½Ã´Â ±æ
·Î±×ÀÎ
ȸ¿ø°¡ÀÔ
KOR
/
ENG
¹ÙÀÌ¿ÀÀǾàǰ»ê¾÷
¹ÙÀÌ¿ÀÀǾàǰÀ̶õ?
¹ÙÀÌ¿ÀÀǾàǰ ½ÃÀå µ¿Çâ
Á¤º¸¸¶´ç
¹ý·É/°í½Ã Á¦°³Á¤ Á¤º¸
»ê¾÷¼Ò½Ä
º¸ÇèÁ¤Ã¥Á¤º¸
»ê¾÷µ¿ÇâÁ¤º¸
E-´º½º·¹ÅÍ
Çùȸ ÀÚ·á½Ç
±³À° ¹× Çà»ç
ÀÏÁ¤Ç¥
Âü°¡½Åû
Á¦Á¶¼öÀÔ°ü¸®ÀÚ±³À°
±³À° ¹× Çà»çÀÚ·á
Dynamic BIO
¼Ò°³
Ȱµ¿¼Ò½Ä
¾Ë¸²¸¶´ç
°øÁö»çÇ×
¾ð·Ðº¸µµÀÚ·á
Çùȸ¼Ò½Ä
KoBIA Gallery
Çùȸ¼Ò°³
Àλ縻
ºñÀü ¹× ¹Ì¼Ç
¿¬Çõ
Á¶Á÷µµ
CI
ȸ¿ø»ç¸®½ºÆ®
ȸ¿ø»ç°¡ÀÔ
ã¾Æ¿À½Ã´Â ±æ
±³À° ¹× Çà»ç
ÀÏÁ¤Ç¥
Âü°¡½Åû
Á¦Á¶¼öÀÔ°ü¸®ÀÚ±³À°
±³À°ÀÏÁ¤
±³À°½Åû
½ÅûȮÀÎ ¹× ¼ö·áÁõÃâ·Â
±³À° ¹× Çà»çÀÚ·á
Âü°¡½Åû
> ±³À° ¹× Çà»ç >
Âü°¡½Åû
ÀüüºÐ·ù
±³À°
¼¼¹Ì³ª
ÄÜÆÛ·±½º
´ÙÀ̳ª¹Í ¹ÙÀÌ¿À
±âŸ
No.
ºÐ·ù
±³À° ¹× Çà»ç¸í
±³À° ¹× Çà»ç ÀÏÁ¤
»óÅÂ
±³À°
[KFDC] 2021 ÀǾàǰ ±ÔÁ¦¾÷¹« Àü¹®°¡ ¾ç¼º±³À° ½Åû ¹× ±³À°°úÁ¤
2021.05.01~2021.08.02
½Åû
400
±³À°
2021³â »ó¹Ý±â ¹ÙÀÌ¿ÀÀǾàǰ Çã°¡½É»ç ¿ª·®°È ¿öÅ©¼ó
2021.04.01~2021.04.01
Á¾·á
399
¼¼¹Ì³ª
[USP Quality Hour 10] New USP Peptide Standards and Related Impurities Characterization
2021.03.30~2021.03.30
Á¾·á
398
´ÙÀ̳ª¹Í ¹ÙÀÌ¿À
2021 ¹ÙÀÌ¿ÀÀǾàǰ Á¤Ã¥¡¤Çã°¡½É»ç ¼³¸íȸ ¹× ´ÙÀ̳ª¹Í¹ÙÀÌ¿À Ãá°è ¿öÅ©¼ó (¿öÅ©¼ó ½ÃÀÛ ½Ã°£ º¯°æ)
2021.03.25~2021.03.25
Á¾·á
397
±³À°
È÷Æ®¾ÆÄ«µ¥¹Ì ½ÇÀü±³À°_ESGÆí
2021.04.07~2021.04.07
Á¾·á
396
ÄÜÆÛ·±½º
¹ÙÀÌ¿ÀÄÚ¸®¾Æ 2021 Àü½Ã Âü°¡ ¾È³»
2021.06.09~2021.06.11
½Åû
395
¼¼¹Ì³ª
USP APEC Pilot CoE Raw Materials for Advanced Therapies Steering Committee Teleconferen
2021.03.02~2021.03.10
Á¾·á
394
¼¼¹Ì³ª
2021 Á¦17Â÷ ´ëÇѹé½ÅÇÐȸ Ãá°èÇмú´ëȸ
2021.03.26~2021.03.26
Á¾·á
393
¼¼¹Ì³ª
[USP Live Webinar] Introduction to GMP Manufacturing and Characterization of Vaccines for Human Use
2021.02.24~2021.02.25
Á¾·á
392
±³À°
Çѱ¹ÀÓ»óCROÇùȸ ¿Â¶óÀÎ CRA ½Å±ÔÀÚ ¹× ½ÉȰúÁ¤ ±³À°»ý ¸ðÁý
2021.02.17~2021.02.23
Á¾·á
1
2
3
4
5
6
7
8
9
10